An open-label study of duloxetine for the treatment of major depressive disorder / Madelaine M. Wohlreich en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 6 (Diciembre)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 6 (Diciembre) . - pp. 552-560 Título : An open-label study of duloxetine for the treatment of major depressive disorder : Comparison of switching versus initiating treatment approaches Tipo de documento: texto impreso Autores: Madelaine M. Wohlreich, Autor ; James M. Martinez, Autor ; Craig H. Mallinckrodt, Autor Fecha de publicación: 2023 Artículo en la página: pp. 552-560 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Citalopram, Trastorno depresivo mayor, Fluvoxamina, Paroxetina, Sertralina. Resumen: This study compared the stabilized duloxetine dose through approximately 12 weeks of treatment in patients initiating duloxetine therapy with that in patients switching to duloxetine from selective serotonin reuptake inhibitors or venlafaxine. All patients met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for major depressive disorder. Link: ./index.php?lvl=notice_display&id=30880 [artículo] An open-label study of duloxetine for the treatment of major depressive disorder : Comparison of switching versus initiating treatment approaches [texto impreso] / Madelaine M. Wohlreich, Autor ; James M. Martinez, Autor ; Craig H. Mallinckrodt, Autor . - 2023 . - pp. 552-560. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 6 (Diciembre) . - pp. 552-560 Palabras clave: Antidepresivos, Citalopram, Trastorno depresivo mayor, Fluvoxamina, Paroxetina, Sertralina. Resumen: This study compared the stabilized duloxetine dose through approximately 12 weeks of treatment in patients initiating duloxetine therapy with that in patients switching to duloxetine from selective serotonin reuptake inhibitors or venlafaxine. All patients met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for major depressive disorder. Link: ./index.php?lvl=notice_display&id=30880

Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptakeiInhibitor treatment / Susan G. Ball en The Journal of Clinical Psychiatry, Año 2016 - Vol.77 - No.5 (Mayo)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.5 (Mayo) . - pp. 635–642 Título : Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptakeiInhibitor treatment Tipo de documento: texto impreso Autores: Susan G. Ball, Autor ; Margaret B. Ferguson, Autor ; James M. Martinez, Autor Fecha de publicación: 2020 Artículo en la página: pp. 635–642 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno depresivo mayor, Terapia Combinada, Inhibidores de la captación de serotonina. Resumen: Three studies examined whether edivoxetine (a highly selective norepinephrine reuptake inhibitor) had efficacy as adjunctive therapy for patients with major depressive disorder (DSM-IV-TR) who were partial responders to selective serotonin reuptake inhibitor (SSRI) treatment of at least 6 weeks’ duration. Link: ./index.php?lvl=notice_display&id=21738 [artículo] Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptakeiInhibitor treatment [texto impreso] / Susan G. Ball, Autor ; Margaret B. Ferguson, Autor ; James M. Martinez, Autor . - 2020 . - pp. 635–642. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.5 (Mayo) . - pp. 635–642 Palabras clave: Trastorno depresivo mayor, Terapia Combinada, Inhibidores de la captación de serotonina. Resumen: Three studies examined whether edivoxetine (a highly selective norepinephrine reuptake inhibitor) had efficacy as adjunctive therapy for patients with major depressive disorder (DSM-IV-TR) who were partial responders to selective serotonin reuptake inhibitor (SSRI) treatment of at least 6 weeks’ duration. Link: ./index.php?lvl=notice_display&id=21738

---

1 (1 - 2 / 2)